NovoSeven 2 mg (100 k.i.e.) prašek in vehikel za raztopino za injiciranje
Eptakog alfa (aktivirani) + voda za injekcije
Composition and organoleptic properties
| Name | Role | Strength | Strength expression |
|---|---|---|---|
| voda za injekcije | — | 2.1 ml/1 ml | — |
| eptakog alfa (aktivirani) | — | 2 mg/1 prašek | — |
Organoleptic description—
Drug status
Announced permanent cessation of marketing of the medicinal product.
Last drug update date:9. 7. 2026